DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,959 | +103203.0% | 2,390 | 0.0% | 0.08% | +8.5% |
| Q2 2023 | $574 | -4.7% | 2,390 | 0.0% | 0.07% | -13.4% |
| Q1 2023 | $602 | -5.0% | 2,390 | 0.0% | 0.08% | -9.9% |
| Q4 2022 | $634 | -100.0% | 2,390 | -90.2% | 0.09% | -90.8% |
| Q3 2022 | $6,309,000 | +2.7% | 24,427 | +0.8% | 0.99% | +9.1% |
| Q2 2022 | $6,146,000 | -13.3% | 24,243 | +0.3% | 0.90% | +0.9% |
| Q1 2022 | $7,090,000 | -11.2% | 24,171 | -0.4% | 0.90% | -2.2% |
| Q4 2021 | $7,981,000 | +1050.0% | 24,258 | +963.9% | 0.92% | +942.0% |
| Q3 2021 | $694,000 | +13.4% | 2,280 | 0.0% | 0.09% | +14.3% |
| Q2 2021 | $612,000 | +19.3% | 2,280 | 0.0% | 0.08% | +8.5% |
| Q1 2021 | $513,000 | +1.4% | 2,280 | 0.0% | 0.07% | -4.1% |
| Q4 2020 | $506,000 | +3.1% | 2,280 | 0.0% | 0.07% | -6.3% |
| Q3 2020 | $491,000 | +21.8% | 2,280 | 0.0% | 0.08% | +9.7% |
| Q2 2020 | $403,000 | +27.5% | 2,280 | 0.0% | 0.07% | +1.4% |
| Q1 2020 | $316,000 | -9.7% | 2,280 | 0.0% | 0.07% | +24.6% |
| Q4 2019 | $350,000 | +6.4% | 2,280 | 0.0% | 0.06% | -9.5% |
| Q3 2019 | $329,000 | +0.9% | 2,280 | 0.0% | 0.06% | 0.0% |
| Q2 2019 | $326,000 | +8.3% | 2,280 | 0.0% | 0.06% | -1.6% |
| Q1 2019 | $301,000 | +28.1% | 2,280 | 0.0% | 0.06% | +14.3% |
| Q4 2018 | $235,000 | -5.2% | 2,280 | 0.0% | 0.06% | +5.7% |
| Q3 2018 | $248,000 | +10.2% | 2,280 | 0.0% | 0.05% | +6.0% |
| Q2 2018 | $225,000 | +0.9% | 2,280 | 0.0% | 0.05% | -3.8% |
| Q1 2018 | $223,000 | -38.9% | 2,280 | -42.0% | 0.05% | -38.1% |
| Q4 2017 | $365,000 | +36.2% | 3,930 | +25.6% | 0.08% | +25.4% |
| Q3 2017 | $268,000 | +1.5% | 3,130 | 0.0% | 0.07% | 0.0% |
| Q2 2017 | $264,000 | -1.5% | 3,130 | 0.0% | 0.07% | -4.3% |
| Q1 2017 | $268,000 | +10.3% | 3,130 | 0.0% | 0.07% | +4.5% |
| Q4 2016 | $243,000 | -0.8% | 3,130 | 0.0% | 0.07% | 0.0% |
| Q3 2016 | $245,000 | -22.5% | 3,130 | 0.0% | 0.07% | -23.0% |
| Q2 2016 | $316,000 | +6.8% | 3,130 | 0.0% | 0.09% | +2.4% |
| Q1 2016 | $296,000 | +2.1% | 3,130 | 0.0% | 0.08% | +9.0% |
| Q4 2015 | $290,000 | +9.0% | 3,130 | 0.0% | 0.08% | +2.6% |
| Q3 2015 | $266,000 | -0.7% | 3,130 | 0.0% | 0.08% | +5.6% |
| Q2 2015 | $268,000 | – | 3,130 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |